Effectiveness and Safety of Omalizumab in the Adjuvant Treatment of Patients With Refractory Acute Urticaria: A Real‐World Case–Control Study

Clinical and Experimental Pharmacology and Physiology · Published 2026-03-01 · DOI 10.1111/1440-1681.70117

Authors being retrieved — see the publisher record. https://doi.org/10.1111/1440-1681.70117

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles